Druggio Logo

Druggio

Novo Nordisk

Novo Nordisk is a pharmaceutical company founded in 1923, specializing in diabetes care, hemophilia, growth disorders, and obesity. They are known for their development of insulin products and other medications for the treatment of chronic diseases. The company focuses on research and innovation to improve outcomes for patients with these conditions.

Novo Nordisk's Drugs

Esperoct

Made by

Novo Nordisk

Approval date

2019/9/20

Treats

Hemophilia
Levemir

Made by

Novo Nordisk

Approval date

2007/10/19

NovoEight

Made by

Novo Nordisk

Approval date

2014/1/17

Treats

Hemophilia
NovoRapid

Made by

Novo Nordisk

Approval date

2001/10/2

NovoSeven

Made by

Novo Nordisk

Approval date

2000/3/10

NovoThirteen

Made by

Novo Nordisk

Approval date

2015/3/26

Ozempic

Made by

Novo Nordisk

Approval date

2018/3/23

Refixia

Made by

Novo Nordisk

Approval date

2018/7/2

Treats

Hemophilia
Sogroya

Made by

Novo Nordisk

Approval date

2021/1/22

Tresiba

Made by

Novo Nordisk

Approval date

2012/9/28

Victoza

Made by

Novo Nordisk

Approval date

2010/1/20